Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Torre Financial. This analysis is provided for institutional research purposes only and is not investment advice.
"LongRun Equity's concentrated quality strategy underperformed in Q2 due to healthcare weakness and AI rotation dynamics. Strong performance from GE Aerospace, software leaders, and new positions in O'Reilly Automotive and Salesforce offset declines in Thermo Fisher and the full exit from UnitedHealth."
LongRun Equity declined 1.2% in Q2 2025 versus a 2.6% benchmark gain, primarily due to weakness in healthcare holdings and AI-perceived risk companies. Key positive contributors included GE Aerospace (+30% on strong earnings), Idexx Laboratories (solid performance with veterinary visit recovery expectations), and software leaders Intuit and Microsoft (both +30% on AI monetization prospects). The fund made two new investments: O'Reilly Automotive, a leading auto parts retailer with outstanding competitive advantages and consistent 6.5% same-store sales growth, and Salesforce, the dominant CRM provider positioned to benefit from AI agents. Healthcare holdings Thermo Fisher and UnitedHealth declined significantly, with UnitedHealth fully sold due to guidance suspension and CEO departure reducing visibility. The fund completed the sale of LVMH, preferring Hermès as a superior luxury business. Portfolio metrics remain strong with 31% operating margins, 76% return on invested capital, and 0.4x net debt to EBITDA. Management expects low double-digit forward returns based on attractive 3.2% free cash flow yield.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High conviction evidenced by concentrated portfolio approach, detailed fundamental analysis of new positions like O'Reilly Automotive, and decisive actions including full exit of UnitedHealth when investment thesis deteriorated. The manager provides specific position sizing context and clear rationale for investment decisions, though some hedging language around market dynamics prevents maximum conviction scoring.
Growth Outlook
The manager expresses cautious optimism about forward returns, expecting low double digits based on attractive valuations and strong portfolio fundamentals. However, the outlook is tempered by acknowledgment of current market challenges including AI rotation dynamics and sector-specific headwinds in healthcare.
Risk Appetite
The fund maintains a concentrated approach with selective new investments in O'Reilly and Salesforce while actively managing risk through the full exit of UnitedHealth. The positioning reflects moderate risk appetite with willingness to add quality names while trimming positions that no longer meet investment criteria.
Capital Deployment
Net neutral deployment with two new investments (O'Reilly Automotive and Salesforce) balanced by two complete sales (LVMH and UnitedHealth). No cash level changes mentioned and the activity represents rotation rather than net deployment or de-risking.
Forward Guidance
Management indicates selective deployment with two new investments while completing two sales, suggesting a measured approach to capital allocation. The expectation of low double-digit forward returns indicates moderate optimism about deployment opportunities ahead.
Language Signal
Language is balanced with positive terms around new investments (outstanding, excellent, strong) offset by risk-focused language around healthcare challenges, AI disruption concerns, and market uncertainty. The tone is professional and measured rather than overtly bullish or bearish.
Perceived Risk
Moderate risk perception with specific concerns about AI disruption effects on certain companies, reduced biotech funding pressuring healthcare valuations, and general market rotation dynamics. Risks are acknowledged but not characterized as systemic or extreme threats.
Opportunity Density
Selective opportunity environment with the manager finding specific attractive investments like O'Reilly Automotive and Salesforce while maintaining focus on quality criteria. The ability to identify and act on new positions suggests reasonable opportunity availability, though selectivity is emphasized.
Time Horizon
Strong long-term orientation evidenced by the investment philosophy of acting as long-term business owners, focus on companies' ability to compound earnings over time, and willingness to hold through short-term volatility. The detailed case study of O'Reilly demonstrates multi-year thesis development typical of patient capital approaches.
